Hims & Hers Health (NYSE: HIMS) has launched a new meal subscription plan focused on providing deeper nutritional support for individuals looking to lose weight

Telomir Pharmaceuticals (NASDAQ: TELO) has been making potential breakthroughs in developing new therapeutics for human longevity with their novel drug.

Hevolution Foundation has announced they have led a $50 million Series A financing round for longevity biotechnology company Aeovian Pharmaceuticals.

Animal longevity biotech startups have been rapidly accelerating, with new clinical trials underway and significant recent venture capital participation.

Animal Biosciences announced the first clinical evidence that their supplement designed to extend lifespan in dogs significantly improves cognitive function.

XPRIZE has launched a new $101M USD prize to incentivize the development of a breakthrough therapeutic for longevity backed by Chip Wilson and Hevolution.

Silicon Valley based startup Loyal is launching a clinical trial to validate their therapeutic longevity drug for extending canine lifespan.

The desire to live longer has long been a focus of startups out of Silicon Valley, but now Saudi Arabia is aiming to become the new global leader.

Through a merger with Serina Therapeutics, AgeX is focused on therapeutics for Parkinson's treatment as well as longevity.